The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2024 | Vaccinations and infection prophylaxis in multiple myeloma
Heinz Ludwig, MD, Wilhelminen Cancer Research Institute, Vienna, Austria, emphasizes the critical role of vaccinations in preventing infections in patients with multiple myeloma (MM). He particularly highlights the importance of vaccines for influenza, pneumococcal disease, and COVID-19. This interview took place at The 10th World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research Funding: Amgen, Takeda, Sanofi
Speaker‘s Bureau, Advisory Boards: Amgen, Takeda, Celgene-BMS, Janssen, Pfizer, Sanofi
